Antimicrobial resistance in shiga toxin-producing escherichia coli O157 and O26 isolates from beef cattle

Japanese Journal of Infectious Diseases

Volumn 65, Issue 2, 2012, Pages 117-121

  Sasaki, Yoshimasa ^a   Usui, Masaru ^a   Murakami, Mariko ^a   Haruna, Mika ^a   Kojima, Akemi ^a   Asai, Tetsuo ^a   Yamada, Yukiko ^a  

^a NATIONAL VETERINARY ASSAY LABORATORY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; APRAMYCIN; AZTREONAM; BICOZAMYCIN; CEFAZOLIN; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTIOFUR; CHLORAMPHENICOL; CLAVULANIC ACID; COLISTIN; DIHYDROSTREPTOMYCIN; ENROFLOXACIN; FLOMOXEF; FOSFOMYCIN; GENTAMICIN; IMIPENEM; KANAMYCIN; NALIDIXIC ACID; OXYTETRACYCLINE; PIPERACILLIN; SHIGA TOXIN; SULFADIMETHOXINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BEEF CATTLE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; ESCHERICHIA COLI O157; ESCHERICHIA COLI O26; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CATTLE DISEASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; MICROBIAL SENSITIVITY TESTS; SHIGA-TOXIGENIC ESCHERICHIA COLI;

EID: 84859063046     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mainil, J.G. and Daube, G. (2005): Verotoxigenic Escherichia coli from animals, humans and foods: who's who? J. Appl. Microbiol., 98, 1332-1344.
2. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour andWelfare (2009): Enterohemorrhagic Escherichia coli infection in Japan as of April 2009. Infect. Agents Surveillance Rep., 30, 119'-120'.
3. Sasaki, Y., Tsujiyama, Y., Kusukawa, M., et al. (2011): Prevalence and characterization of Shiga toxin-producing Escherichia coli O157 and O26 in beef farms. Vet. Microbiol., 150, 140-145.
4. Ramchandani, M., Manges, A.R., DebRoy, C., et al. (2005): Possible animal origin of human-associated multidrug-resistant uropathogenic Escherichia coli. Clin. Infect. Dis., 40, 251-257.
5. Kobayashi, H., Kanazaki, M., Ogata, T., et al. (2009): Changing prevalence of O-serogroups and antimicrobial agent susceptibility among STEC strains isolated from healthy dairy cows over a decade in Japan between 1998 and 2007. J. Vet. Med. Sci., 71, 363-366.
6. Ministry of Agriculture, Forestry, and Fisheries in Japan (2009): Production of various kinds of meat. Monthly Stat. Agric. Forest. Fish., 682, 43.
7. Paton, J.C. and Paton, A.W. (1998): Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev., 11, 450-479.
8. Wong, C.S., Jelacic, S., Habeeb, R.L., et al. (2000): The risk of the haemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J. Med., 342, 1930-1936.
9. Clinical and Laboratory Standards Institute (2008): Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; 3rd edition: Approved standard M31-A3. Clinical and Laboratory Standards Institute, Wayne, Pa.
10. Clinical and Laboratory Standards Institute (2008): Performance standards for antimicrobial susceptibility testing; 18th Informational Supplement M100-S18. Clinical and Laboratory Standards Institute, Wayne, Pa.
11. National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries (2009): A Report on the Japanese Veterinary Antimicrobial Resistance Monitoring System-2000 to 2007-. Available at .
12. Luzzaro, F., Mantengoli, E., Perilli, M., et al. (2001) Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase. J. Clin. Microbiol., 39, 1865-1870.
13. Kojima, A., Ishii, Y., Ishihara, K., et al. (2005): Extended-spectrum- β -lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program. Antimicrob Agents Chemother., 49, 3533-3537.
14. CTX-M genes by multiplex PCR assay. J. Med. Microbiol., 54, 1183-1187.
15. Dallenne, C., Da Costa, A., Decreá, D., et al. (2010): Development of a set of multiplex PCR assays for the detection of genes encoding important β -lactamases in Enterobacteriaceae. J. Antimicrob. Chemother., 65, 490-495.
16. Asai, T., Kojima, A., Harada, K., et al. (2005): Correlation between the usage volume of veterinary therapeutic antimicrobials and resistance in Escherichia coli isolated from the feces of foodproducing animals in Japan. Jpn. J. Infect. Dis., 58, 369-372.
17. Harada, K. and Asai, T. (2010): Role of antimicrobial agent selective pressure and secondary factors on antimicrobial resistance prevalence in Escherichia coli from food-producing animals in Japan. J. Biomed. Biotechnol. Doi: 10.1155/2010/180682.
18. Mora, A., Blanco, J.E., Blanco, M., et al. (2005): Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain. Res. Microbiol., 156, 793-806.
19. Higami, S., Nishimoto, K., Kawamura, T., et al. (1997): Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak. J. Jpn. Assoc. Infect. Dis., 72, 266-272 (in Japanese).
20. Ikeda, K., Ida, O., Kimoto, K., et al. (1999): Effect of early fosfomycin treatment on prevention of haemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Clin. Nephrol., 52, 357-362.
21. Kasahara, H., Ueda, H., Kurogami, Y., et al. (2011): Outbreak of EHEC O26 infection through playing with water in a park spreading in a nursery school, July-August 2010-Nagano. Infect. Agents Surveillance Rep., 32, 132-133 (in Japanese).
22. Hiroi, M., Harada, T., Kawamori, F., et al. (2011): A survey of b-lactamase-producing Escherichia coli in farm animals and raw retail meat in Shizuoka Prefecture, Japan. Jpn. J. Infect. Dis., 64, 153-155.
23. Ishii, Y., Kimura, S., Alba, J., et al. (2005): Extended-spectrum β -lactamase-producing Shiga toxin gene (stx1)-positive Escherichia coli O26:H11: a new concern. J. Clin. Microbiol., 43, 1072-1075.
24. Caroff, N., Espaze, E., Gautreau, D., et al. (2000): Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J. Antimicrob. Chemother., 45, 783-788.
25. Siu, L.K., Lu, P.L., Chen, J.Y., et al. (2003): High-level expression of ampC β -lactamase due to insertion of nucleotides between-10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment. Antimicrob. Agents Chemother., 47, 2138-2144.
26. Tracz, D.M., Boyd, D.A., Hizon, R., et al. (2007): ampC gene expression in promoter mutations of cefoxitin-resistant Escherichia coli clinical isolates. FEMS Microbiol. Lett., 270, 265-271.
27. Horii, T., Kimura, T., Sato, K., et al. (1999): Emergence of fosfomycin- resistant isolates of Shiga-like toxin-producing Escherichia coli O26. Antimicrob. Agents Chemother., 43, 789-793.
28. Nishikawa, Y., Zhou, Z., Hase, A., et al. (2000): Relationship of genetic type of Shiga toxin to manifestation of bloody diarrhea due to enterohemorrhagic Escherichia coli serogroup O157 isolates in Osaka city, Japan. J. Clin. Microbiol., 38, 2440-2442.
29. Kawano, K., Okada, M., Haga, T., et al. (2008): Relationship between pathogenicity for humans and stx genotype in Shiga toxinproducing Escherichia coli serotype O157. Eur. J. Clin. Microbiol. Infect. Dis., 27, 227-232.
30. Nakamura, H., Ogasawara, J., Kita, T., et al. (2008): Typing of Stx2 genes of Escherichia coli O157 isolates from cattle. Jpn. J. Infect. Dis., 61, 251-252.